All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: HIV Infections-28167814
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 28167814 A71T
PR
gag-pol
HIV Infections
D
G
R
S
L
View
2 28167814 A71V
PR
gag-pol
HIV Infections
D
G
R
S
L
View
3 28167814 D121E
gp41
Env
HIV Infections
G
R
S
L
View
4 28167814 D60E
PR
gag-pol
HIV Infections
D
G
R
S
L
View
5 28167814 E137K
gp41
Env
HIV Infections
D
G
R
S
L
View
6 28167814 E138A
RT
gag-pol
HIV Infections
D
G
R
S
L
View
7 28167814 E138K
RT
gag-pol
HIV Infections
D
G
R
S
L
View
8 28167814 G16E
PR
gag-pol
HIV Infections
D
G
R
S
L
View
9 28167814 G73S
PR
gag-pol
HIV Infections
D
G
R
S
L
View
10 28167814 H132Y
gp41
Env
HIV Infections
G
R
S
L
View
11 28167814 H69K
PR
gag-pol
HIV Infections
D
G
R
S
L
View
12 28167814 I62V
PR
gag-pol
HIV Infections
D
G
R
S
L
View
13 28167814 I64L
PR
gag-pol
HIV Infections
D
G
R
S
L
View
14 28167814 I64V
PR
gag-pol
HIV Infections
D
G
R
S
L
View
15 28167814 I69V
gp41
Env
HIV Infections
G
R
S
L
View
16 28167814 I93L
PR
gag-pol
HIV Infections
D
G
R
S
L
View
17 28167814 K20R
PR
gag-pol
HIV Infections
D
G
R
S
L
View
18 28167814 L10I
PR
gag-pol
HIV Infections
D
G
R
S
L
View
19 28167814 L10V
PR
gag-pol
HIV Infections
D
G
R
S
L
View
20 28167814 L33I
PR
gag-pol
HIV Infections
D
G
R
S
L
View
21 28167814 L33V
PR
gag-pol
HIV Infections
D
G
R
S
L
View
22 28167814 L63P
PR
gag-pol
HIV Infections
D
G
R
S
L
View
23 28167814 M36I
PR
gag-pol
HIV Infections
D
G
R
S
L
View
24 28167814 M36L
PR
gag-pol
HIV Infections
D
G
R
S
L
View
25 28167814 N125D
gp41
Env
HIV Infections
G
R
S
L
View
26 28167814 N126K
gp41
Env
HIV Infections
D
G
R
S
L
View
27 28167814 N42S
gp41
Env
HIV Infections
G
R
S
L
View
28 28167814 T74S
PR
gag-pol
HIV Infections
D
G
R
S
L
View
29 28167814 V106I
RT
gag-pol
HIV Infections
D
G
R
S
L
View
30 28167814 V118I
RT
gag-pol
HIV Infections
D
G
R
S
L
View
31 28167814 V77I
PR
gag-pol
HIV Infections
D
G
R
S
L
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.